Satellos Bioscience Inc. Common Stock - Asset Resilience Ratio

Latest as of June 2026: 82.78%

Satellos Bioscience Inc. Common Stock (MSLE) has an Asset Resilience Ratio of 82.78% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is Satellos Bioscience Inc. Common Stock's working capital to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

$54.38 Million

Cash + Short-term Investments

Total Assets

$65.69 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2007–2025)

This chart shows how Satellos Bioscience Inc. Common Stock's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Satellos Bioscience Inc. Common Stock asset portfolio.

Liquid Assets Composition Over Time

This chart breaks down Satellos Bioscience Inc. Common Stock's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Satellos Bioscience Inc. Common Stock long-term investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$54.38 Million	82.78%
Total Liquid Assets	$54.38 Million	82.78%

Asset Resilience Insights

Very High Liquidity: Satellos Bioscience Inc. Common Stock maintains exceptional liquid asset reserves at 82.78% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Satellos Bioscience Inc. Common Stock Industry Peers by Asset Resilience Ratio

Compare Satellos Bioscience Inc. Common Stock's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Aurinia Pharmaceuticals Inc NASDAQ:AUPH	Biotechnology	33.23%
Nanobiotix NASDAQ:NBTX	Biotechnology	4.71%
Innovita Biological Technology Co. Ltd. A SHG:688253	Biotechnology	65.12%

Annual Asset Resilience Ratio for Satellos Bioscience Inc. Common Stock (2007–2025)

The table below shows the annual Asset Resilience Ratio data for Satellos Bioscience Inc. Common Stock.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	56.15%	$17.91 Million	$31.89 Million	+39.45pp
2024-12-31	16.70%	$8.50 Million	$50.88 Million	-22.85pp
2023-12-31	39.55%	$17.52 Million	$44.30 Million	+38.66pp
2020-12-31	0.89%	$10.07K	$1.13 Million	-25.45pp
2015-12-31	26.34%	$1.02 Million	$3.89 Million	-2.11pp
2014-12-31	28.45%	$1.93 Million	$6.77 Million	+8.12pp
2013-12-31	20.33%	$758.44K	$3.73 Million	-1.60pp
2012-12-31	21.93%	$662.25K	$3.02 Million	-14.42pp
2011-12-31	36.35%	$1.07 Million	$2.94 Million	-16.22pp
2010-12-31	52.57%	$1.42 Million	$2.69 Million	-1.69pp
2009-12-31	54.26%	$2.51 Million	$4.63 Million	+52.97pp
2007-12-31	1.29%	$42.00K	$3.27 Million	--

pp = percentage points

About Satellos Bioscience Inc. Common Stock

NASDAQ:MSLE USA Biotechnology

Market Cap

$198.59 Million

Market Cap Rank

#16667 Global

#3963 in USA

Share Price

$9.36

Change (1 day)

-4.39%

52-Week Range

$5.59 - $13.01

All Time High

$13.01